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ABSTRACT Lipid-protein interactions are rarely char-
acterized at a structural molecular level due to technical
difficulties; however, the biological significance of un-
derstanding the mechanism of these interactions is
outstanding. In this report, we provide mechanistic
insight into the inhibitory complex formation of the
lipid mediator sphingosylphosphorylcholine with cal-
modulin, the most central and ubiquitous regulator
protein in calcium signaling. We applied crystallo-
graphic, thermodynamic, kinetic, and spectroscopic
approaches using purified bovine calmodulin and bo-
vine cerebral microsomal fraction to arrive at our
conclusions. Here we present 1) a 1.6-Å resolution
crystal structure of their complex, in which the sphin-
golipid occupies the conventional hydrophobic binding
site on calmodulin; 2) a peculiar stoichiometry-depen-
dent binding process: at low or high protein-to-lipid
ratio calmodulin binds lipid micelles or a few lipid
molecules in a compact globular conformation, respec-
tively, and 3) evidence that the sphingolipid displaces
calmodulin from its targets on cerebral microsomes.
We have ascertained the specificity of the interaction
using structurally related lipids as controls. Our obser-
vations reveal the structural basis of selective calmod-
ulin inhibition by the sphingolipid. On the basis of the
crystallographic and biophysical characterization of the
calmodulin–sphingosylphosphorylcholine interaction,
we propose a novel lipid-protein binding model, which
might be applicable to other interactions as well.—
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Calmodulin (CaM), the ubiquitous Ca2 sensor of
eukaryotic cells, is involved in a wide variety of signal-
ing events, regulating numerous proteins, including
kinases, phosphatases, ion channels, and pumps (1).
CaM is a small (148 residues), acidic (pI4.1),
evolutionarily conserved protein, comprising homol-
ogous N- and C-terminal globular domains con-
nected by a flexible central linker. Both domains
possess a pair of -helical Ca2-binding EF-hand
motifs (2). Association with Ca2 induces the expo-
sure of hydrophobic patches on CaM that allow
binding of target proteins (3); in these complexes,
CaM adopts a compact globular structure wrapped
around its targets (4, 5). Key modulation of CaM
function via Ca2 binding was described decades
ago. So far, no other second messenger has been
shown to directly regulate CaM activity. The pharma-
cologic inhibitors of CaM are all synthetic aromatic
molecules, of which trifluoperazine (TFP) is the most
well characterized (6 – 8). There are reports on nat-
ural compounds presenting anti-CaM activity (9, 10),
but these substances can only be found in certain
species; they are not universal to eukaryotic or even
mammalian cells.
Previously, we have demonstrated that sphingo-
sylphosphorylcholine (SPC), a putative lipid second
messenger (11, 12), can selectively bind to CaM and
inhibit the protein’s activity on target enzymes cal-
cineurin and phosphodiesterase, while structurally sim-
ilar lysophospholipid mediators, such as sphingosine-1-
phosphate (S1P), lysophosphatidylcholine (LPC), and
lysophosphatidic acid (LPA), showed no effect (13).
This finding proposes a novel type of endogenous
regulation for CaM and also suggests an intracellular
target for SPC, the newly recognized sphingolipid me-
diator. Information on SPC metabolism is rather scarce
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compared to the intensively studied S1P and ceramide,
yet SPC has been detected under several physiological
and pathological conditions (14–17).
Here, we give an in-depth structural and mechanistic
characterization of CaM binding to SPC. We believe
that our results largely contribute to the understanding
of lipid-protein interactions and that the inhibitory
CaM-SPC complex might be of particular importance
in cellular signaling.
MATERIALS AND METHODS
Preparation of CaM and SPC solutions
CaM was purified from bovine brain according to Go-
palakrishna and Anderson (18), using phenyl-Sepharose
affinity chromatography as the main purification step.
d-erythro-sphingosylphosphorylcholine was purchased
from Avanti Polar Lipids (Alabaster, AL, USA) and was
delivered from a 10 mM methanolic stock solution.
X-ray crystallography
CaM and SPC were cocrystallized using the sitting drop
method at room temperature. Protein solution (2 l) at 1
mM concentration was mixed with an equal volume of
precipitant solution and 10 mM SPC solution in methanol, as
well as 1.5 l 0.5% LM agarose gel. The precipitant solution
was 50 mM sodium cacodylate adjusted to pH 5.5 and
containing 10 mM CaCl2, 10 mM MgCl2, and 28% (w/v)
polyethylene glycol 8000. Microseeding was carried out 24 h
after setting up crystallization. The cryosolution contained
10% glycerol.
Data were collected at the ID 23-1 beamline of the Euro-
pean Synchrotron Radiation Facility. Wavelength of the beam
was 0.97620 Å, and temperature was set to 100 K. Data were
processed using Mosflm (19) and scaled using the SCALA
program (20). The crystals are isostructural with structures of
CaM complexed with various small molecules (TFP, arylalky-
lamine).
The structure was solved by molecular replacement using
the program MOLREP (21) of the Collaborative Computa-
tional Project 4 (22). The N- and C-terminal CaM domains of
PDB entry 1LIN were used as search models. Refinement was
carried out with the REFMAC5 program, using TLS refine-
ment and restrained maximum likelihood refinement (23).
One TLS domain was defined for both CaM domains and one
for the SPC molecules. Hydrogen atoms were generated in
the riding positions. Model building was carried out using the
Coot program (24).
The final model contains CaM residues 3–78 and 80–146,
with 12 disordered side chains and 3 side chains in alternate
positions, as well as 4 calcium ions, 4 SPC molecule fragments,
and 79 water molecules. The stereochemistry of the structure
was assessed with PROCHECK (25), 94.4 and 5.6% of the
CaM residues are in the most favored and additional allowed
regions of the Ramachandran plot, respectively. Data collec-
tion and refinement statistics are shown in Table 1. The
atomic coordinates and structure factors were deposited in
the PDB with accession code 3IF7.
Isothermal titration calorimetry
Thermodynamics of the interaction of Ca2CaM and
apoCaM with SPC was examined using a VP-ITC instrument
(MicroCal, Piscataway, NJ, USA). Five- to 10-l aliquots of the
protein at a concentration of 300 or 75 M in a buffer
containing 10 mM HEPES, pH 7.4; 100 mM KCl; and either 5
mM CaCl2 or 1 mM EGTA was injected into the ITC cell
containing 200 M SPC in the same buffer at 25°C. A time
interval of 10 minutes was applied between injections. The
analysis of titration curves and the energetics calculations
were done using the Origin software provided by MicroCal.
Dynamic light scattering
Size distributions of SPC-CaM solutions were assessed by an
ALV goniometer with a Melles Griot diode-pumped solid-
state laser at 457.5 nm wavelength (type: 58 BLD 301). The
intensity of the scattered light was measured at 90° at room
temperature. The autocorrelation function was calculated
using an IBM PC-based data acquisition system developed in
the Institute of Biophysics and Radiation Biology, Semmel-
weis University. The most probable particle distribution was
estimated using the maximum entropy method that produces
normalized distribution (26). The hydrodynamic radii of the
particles were calculated based on the Einstein-Stokes equa-
tion. Size distributions calculated in this manner bear a se of
5%. Micelle size distribution is essentially independent of
total SPC concentration (27); we therefore optimized SPC
concentrations for the best signal-to-noise ratios.
ANS fluorescence
Micelle integrity was monitored using the fluorescent
hydrophobic probe 8-anilinonapthalene-1-sulfonic acid
TABLE 1. Data collection and refinement statistics for the Ca2
CaM/SPC complex
Parameter Ca2CaM/SPC
Data collection
Space group P 3221
Cell dimensions
a, b, c (Å) 39.67, 39.67, 170.34
, ,  (°) 90, 90, 120
Resolution (Å) 29.393–1.60 (1.69–1.60)
Rmerge
a 0.105 (0.446)
I/I 12.3 (4.1)
Completeness (%) 100.0 (100.0)
Redundancy 8.6 (7.9)
Refinement
Resolution (Å) 29.09–1.60 (1.64–1.60)
Reflections 20,426 (1554)
Rwork/Rfree 0.195/0.238 (0.200/0.252)
Atoms
Protein 1096
Ligand/ion 80 SPC/4Ca2
Water 79
B factors (Å2) (net/residual)b
Protein 32.168/26.664
Ligand 71.108/48.393
Ion 21.570/18.778
Water 34.547
R.m.s. deviations
Bond lengths (Å) 0.025
Bond angles (°) 2.085
Values in parentheses are for highest-resolution shell. aA high-
resolution and a low-resolution data set were collected from the same
crystal and were merged. bNet B factors are sum of the residual and
TLS contributions.
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(ANS; Fluka 10417; Sigma-Aldrich, St. Louis, MO, USA) (28)
on a Jobin Yvon Fluoromax-3 spectrofluorometer (Jobin Yvon
Horiba, Longiumeau, France) at 25°C. 5 M ANS in a
solution of 200 M SPC; 10 mM HEPES, pH 7.4; 100 mM KCl;
and either 5 mM CaCl2 or 1 mM EGTA was titrated with CaM
in a concentration range of 0.1–20 M in case of apoCaM and
0.1–40 M in case of Ca2CaM. The fluorophore was excited
at 388 nm; emission was monitored from 400 to 600 nm. The
excitation slit was adjusted to 2 nm, the emission slit was
adjusted to 5 nm, and the maximum intensities were read.
Stopped-flow measurements
Dansyl-CaM was prepared according to Kovacs et al. (13).
Fluorescence time courses were recorded at 25°C in buffers 10
mM HEPES, pH 7.4; 100 mM KCl; and either 5 mM CaCl2 or 1
mM EGTA, using an SX-20 (Applied Photophysics, Surrey, UK)
stopped-flow apparatus having 2 ms dead time. Dansyl fluores-
cence was excited at 340 nm, and emission was selected with a
455-nm long-pass filter. At least 5 individual curves were col-
lected and averaged for each data point. Time courses were
analyzed using the curve-fitting software provided with the
stopped-flow apparatus or by Origin 7 (OriginLab Corp.,
Northampton, MA, USA). The amplitude vs. concentration
curves were fitted with the following quadratic equation (de-
rived in ref. 29):
	AB
  s  Amp 
c x K c x K2  4  c  x
2
where [AB] is the concentration of the complex, s is y at x 
0, Amp is amplitude, c is the concentration of the constant
component, and K is the dissociation constant.
Measurement of CaM binding to its cerebral microsomal
targets
Cerebral microsomes were isolated from bovine brain by
differential centrifugation based on the procedure of Volpe et
al. (30). The interaction between microsomal proteins and
CaM was monitored using the fluorescence of dansyl-labeled
CaM in a Jobin Yvon Fluoromax-3 spectrofluorometer at 25°C
in 10 mM HEPES, pH 7.4; 100 mM KCl; and 1 mM CaCl2.
Bandwidths were set to 5 nm. Dansyl was excited at 340 nm;
emission was monitored from 400 to 600 nm. Microsomal
protein and dansyl-CaM concentrations were 0.5 mg/ml and
0.2 M, respectively. Each spectrum was corrected for corre-
sponding lipid, protein, and buffer effects by subtracting a
matching buffer scan.
RESULTS
Crystal structure of the Ca2CaM/SPC complex
The crystal structure of the Ca2CaM/SPC complex
was refined to 1.6 Å resolution (Fig. 1). The protein is
well defined by electron density, except for the central
linker region and the ends of the protein chain known
to be highly flexible and often disordered in CaM
structures (4–6, 31). The protein is in a collapsed
conformation with a binding channel of mainly hydro-
phobic character formed between its two domains. The
hydrophobic pockets known to be adaptable to the
bound ligand are open.
Four SPC molecules could be identified in the calcu-
lated electron density maps (Supplemental Fig. S1).
Their most rigid parts are the long extended alkyl
chains bound in nearly parallel positions. The binding
channel between the two calmodulin domains is filled
by these four chains. Parts of SPC molecules farther
from the center of the complex show higher mobility
with their B-factor values similar to the central linker
region of the protein (Fig. 2). The alkyl chains of the
sphingosyl moiety spread outside the binding channel
(17 Å long), and the overhangs are disordered. The
phosphocholine moieties could be built in electron
density maps fully for two SPC molecules and partially
for the third one; however, they show significantly
lower electron density than the alkyl chains. Two of the
SPC molecules are bent near their phosphate moieties
and fill the hydrophobic pockets of CaM, while their
positively charged choline groups are pointing toward
the acidic regions of CaM, forming electrostatic inter-
actions. The strongest electrostatic interactions of these
charged choline groups are established with Glu11 and
Glu127 (2.9–3 Å), as well as with Glu54 and Glu123
Figure 1. Overall structure of the Ca2CaM/SPC complex. A)
Side view shows SPC1 and SPC2 bound in quasi-symmetry-
related positions occupying the hydrophobic pockets of CaM.
B) Top view shows the 4 SPC molecules bound in nearly
parallel orientations. Note that not all parts of the SPC
molecules can be identified in the electron density map (see
text for further details). Figure was prepared using PyMol
(DeLano Scientific LLC, South San Francisco, CA, USA).
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(5.4 Å). The low occupancy of the phosphocholine
moieties suggests that they are partially disordered in
the crystal and possibly flexible in solution. This results
in a nondirected binding of the phosphocholine head-
group and in a possible mobility of the SPC molecule
along its axis within the binding channel.
Most importantly, the overall conformation of CaM is
well defined in our crystal structure and resembles its
complexes with the small molecules TFP (8) and the
arylalkylamine derivative AAA (6) and many of its
peptide complexes (e.g., refs. 4, 5) (Fig. 3). Accord-
ingly, residues involved in SPC binding could be also
mapped to the small molecule inhibitor and target
peptide binding sites (Supplemental Fig. S2). In the
Ca2CaM/SPC complex, CaM is in a collapsed overall
conformation with SPC molecules bound between the
two CaM domains. The fact that the lipid occupies the
same binding pocket as the target peptides of CaM
explains competitive inhibition witnessed in the cal-
cineurin functional assay (13) and in peptide-binding
assays (29).
Isothermal titration calorimetry provides clues for a
2-step binding model
During preliminary studies on the interaction between
SPC and CaM (13), we have found that in order to
efficiently bind to the protein, the lipid has to be
clustered, that is, in vitro, it has to form micelles. We
have determined the CMC of SPC to be 33  2 M (13)
and estimated a micelle to consist of 50–150 mono-
mers, based on geometric calculations. As a conse-
quence of this mode of binding, the characterization of
the interaction requires special treatment. Hence, in-
stead of applying the conventional isothermal titration
calorimetry (ITC) experimental setup of ligand injec-
tion, we injected the protein into the cell containing
200 M SPC. By keeping the lipid concentration con-
stant, well above its critical micelle concentration, we
avoided the heat effects caused by the change in the
micellar state of the lipid.
In contrast to traditional CaM inhibitors, which bind
only to Ca2CaM (8, 32), SPC binds both in the
presence and absence of Ca2 (13). Therefore, we
carried out experiments with both Ca2CaM and
apoCaM (Fig. 4). Parameters obtained from the fitting
process are presented in Table 2. H, S, and Kd values
correspond to the binding of one CaM molecule to one
Figure 2. Comparison of the mobility of SPC molecules and CaM. A) Total atomic B factors of the protein backbone atoms (in
rainbow colors) and SPC atoms (light orange) represented as thermal ellipsoids. Arrows show B factor growing along SPC
chains. Most mobile regions of the complex are the central linker region of CaM (residues 75–81) and SPCs. Figure was drawn
using CCP4mg (39). B) B-factor plot of the structure.
Figure 3. Conformation of Ca2CaM in the Ca2CaM/SPC
structure is collapsed, similarly to Ca2CaM complexes with
small molecules and most of its target peptides. A) Structural
alignment with the Ca2CaM/4TFP complex (PDB accession
code 1LIN). N- and C-terminal CaM domains of the
Ca2CaM/SPC complex are shown in blue and red, respec-
tively. Compared structure is shown in lighter colors. Carbon
atoms of the SPC and TFP molecules are shown in orange and
green, respectively. B) Structural alignment with the Ca2CaM/
myosin light-chain kinase target peptide complex (PDB acces-
sion code 2K0F). Target peptide is shown in cyan, with its
residues anchoring in the hydrophobic pockets of CaM shown as
sticks. Figure was prepared using PyMol (DeLano Scientific).
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apparent binding site. Both titrations generated two
clearly distinguishable binding processes. The binding
of apoCaM to SPC was very similar to Ca2CaM binding
to the lipid, only it took place in a narrower concentra-
tion range, that is, with different stoichiometry (see
inset in Fig. 4). In case of apoCaM, we observed an
additional endothermic heat reaction, which gradually
decreased during the whole experiment and over-
lapped with the two binding reactions (Supplemental
Fig. S3). We interpreted this process as micelle rear-
rangement, the effect of which could be removed by
subtraction for the whole concentration range, yielding
an undistorted double-binding curve for data evalua-
tion. Parameters given for the first process of the
Ca2CaM titration should be taken as approximate
values (Table 2), because the beginning of the reaction
could not be resolved. In general, the observed stoichi-
ometry range for the SPC–CaM interaction is similar to
what we and others have found previously for other
lipid-protein interactions (33, 34).
The stoichiometry of the two binding processes en-
abled us to envisage the following scenarios. The first,
stronger binding, for which the fitting process yielded a
stoichiometry of 100–200 SPC monomers/protein and
a Kd of 61  10 nM for Ca
2CaM, and a stoichiometry
of 164  5 SPC monomers/protein and a Kd of 2.4 
0.4 nM for apoCaM, may be interpreted as the binding
of the protein to available surfaces on micelles. The
second binding process is weaker, yielding a stoichi-
ometry of 7  0.15 SPC monomers/protein and a Kd
of 2.1  0.2 M for Ca2CaM and a stoichiometry of
40  1 SPC monomers/protein and a Kd of 0.22 
0.03 M for apoCaM, and could result from addi-
tional protein molecules binding to the micelles.
However, this scenario is quite unlikely in the case of
Ca2CaM, where the estimated number of SPC
monomers per protein molecule is 7 at the end of the
second ITC phase. This would mean that 30 CaM
molecules bind to one micelle, which is hardly pos-
sible considering that the size of the protein and the
micelle are comparable (see dynamic light-scattering
results for evidence). More likely, the binding of
further CaMs could result in the disintegration of
micelles by the protein. Ca2CaM could then isomerize
in a collapsed conformation wrapped around only a few
SPC monomers, as we see it in our crystal structure.
ApoCaM, on the other hand, follows a reaction with the
stoichiometry of 40 SPC monomers/protein. This
stoichiometry would allow the binding of several
apoCaM molecules to one micelle or, alternatively, the
disintegration of micelles into smaller “parts” stabilized
by the protein.
Considering the enthalpy and entropy values (Table
2), we can conclude that both reactions are entropically
largely unfavorable. A study of Brokx et al. (35) on
target peptide binding by CaM revealed that binding
can be either entropically or enthalpically driven, but
even in the second case, it is only slightly unfavorable
entropically with the highest TS value of approxi-
mately 5 kcal/mol. In contrast, our titrations yielded
TS values of 46 and 65 kcal/mol for the first
reaction and 15 and 15.5 kcal/mol for the second
reaction, in case of Ca2CaM and apoCaM, respec-
tively. Accordingly, our H values are larger compared
to the results of Brokx et al. (35) who obtained H
values between approximately 15 and 15 kcal/mol
in contrast to our 56  1 and 77  1 kcal/mol for
the first reaction and 22.9  0.5 and 24.7  0.6
kcal/mol for the second reaction for Ca2CaM and
TABLE 2. Thermodynamic parameters of the CaM–SPC interaction obtained from ITC measurements
First process Second process
n1 Kd1 (nM)
H1
(kcal/mol)
TS1
(kcal/mol) n2 Kd2 (M)
H2
(kcal/mol)
TS2
(kcal/mol)
Ca2CaM 100–200a 61  10 56  1 46 7  0.15 2.1  0.2 22.9  0.5 15
ApoCaM 164  5 2.4  0.4 77  1 65 40  1 0.22  0.03 24.7  0.6 15.5
n1 and n2 are the numbers of SPC molecules bound by one CaM molecule for the given binding process. H, S, and Kd are values
corresponding to the binding of one CaM molecule to one apparent binding site. TS  R  T  ln Kd  H. Reliability of the fittings is shown
by the error values. Each experiment was repeated 3 times. Deviation between the individual measurements was found to be 5%. aThe fitting
provided acceptable results in this n1 range; Kd1 and H1 values are calculated for n1  200.
Figure 4. Calorimetric traces of titrating 200 M SPC with
Ca2CaM (E) or apoCaM (). Inset depicts the titration with
apoCaM on a more appropriate scale. Solid lines show the fit
by a 2-site binding model provided by the Origin for ITC
software, yielding parameters listed in Table 2.
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apoCaM, respectively. On the other hand, G (around
10 kcal/mol) and Kd values (in the nanomolar range)
are similar for interactions of CaM with target peptides
and SPC. The large differences in the thermodynamic
properties between SPC–CaM and single ligand–CaM
interactions could be explained by the different nature
of the two interactions. In our experiments, the initial
state of SPC is micellar, not monomeric, and instead of
one ligand, a CaM molecule embraces several SPC
molecules on binding.
Dynamic light scattering affirms that CaM first binds
to SPC micelles, which are then disintegrated by the
protein
To ascertain the size distribution profile of SPC–CaM
mixtures of varying stoichiometries, dynamic light scat-
tering (DLS) measurements were carried out (Fig. 5).
It is worth noting that the intensity dimension of the
DLS data is not informative, since it is greatly influ-
enced by the larger contaminating particles in the
solution that vary from sample to sample. To compare
the size distributions of the species present, curves were
normalized to their area. The Rh values of the peaks
correspond to the average hydrodynamic radii of the
particles, and are, therefore, the relevant values char-
acterizing the size of a given particle. Samples of 40 M
Ca2CaM and 40 M apoCaM both gave homogenous
size distributions of 3.3 nm and 2.6 nm hydrodynamic
radii, respectively, in accordance with preceding re-
ports (36). A sample of pure SPC micelles revealed that
micelles have an average hydrodynamic radius of 3.1
nm. In mixtures of 200 M SPC with 8 M Ca2CaM or
3 M apoCaM (concentrations near the end of the first
ITC phase), an increase in particle size could be
observed compared to SPC-free Ca2CaM and apoCaM
(Fig. 5); 200 M SPC with 8 M Ca2CaM yielded
particles with an average hydrodynamic radius of 5 nm,
while 200 M SPC with 3 M apoCaM yielded particles
with an average hydrodynamic radius of 4.5 nm. At
concentrations corresponding to the end of the second
ITC phase, 200 M SPC with 40 M Ca2CaM or 12 M
apoCaM, the size distribution profile decreased sub-
stantially in agreement with the hypothesis that the
large protein–micelle particles are disintegrating. The
size distribution became less homogenous, a small
amount of the large complexes could still be observed.
In case of Ca2CaM, the resulting particles are signifi-
cantly smaller than Ca2CaM alone, which indicates
that the protein adopts a more compact conformation.
Together with the 7 SPC monomers/protein stoichiom-
etry estimated from the ITC fitting, this suggests that
the ensuing Ca2CaM/SPC complex is in the typical
collapsed conformation seen in Ca2CaM/inhibitor
and Ca2CaM/target peptide complexes.
ANS fluorescence reveals the disruption of SPC
micelles by CaM
To further verify the proposed model, we monitored
micelle integrity during titration with CaM. Under
conditions identical to that of ITC experiments, we
followed the fluorescence of the hydrophobic probe,
ANS. As the intensity of ANS fluorescence increases
greatly when incorporated into lipid micelles (28), it is
well suited to certify the presence of micelles in a
solution. The change in ANS fluorescence in the pres-
ence of 200 M SPC on incremental addition of
Ca2CaM or apoCaM is depicted in Fig. 6. It is clearly
demonstrated that increasing protein concentration
disrupts micelles; moreover, their disruption occurs
in the same range of molar ratios (0.02– 0.2 for
Ca2CaM and 0.01– 0.05 for apoCaM) as the second
phase of the ITC measurements. This observation
along with the results of the DLS measurements
strongly argues for the explanation that the second
phase witnessed in ITC experiments is a micelle
disintegration process.
Kinetic properties of the 2-step binding process
We previously determined several kinetic parameters of
the CaM–SPC interaction but only at relatively low
Figure 5. Dynamic light-scattering profiles of different CaM-
SPC solutions in case of Ca2CaM (A) and apoCaM (B).
Symbols represent 500 M SPC (), 40 M Ca2CaM (Œ), 40
M apoCaM (‚), 200 M SPC with 8 M Ca2CaM (F), 200
M SPC with 3 M apoCaM (E) (plateau of the first ITC
phase), 200 M SPC with 40 M Ca2CaM (f), and 200 M
SPC with 12 M apoCaM () (plateau of the second ITC
phase). Note that curves are normalized to their area, and
their amplitudes are not informative. Rh values correspond-
ing to the peaks describe the average size distribution of the
population.
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CaM-to-SPC ratios (29). In the current study, we aimed
at characterizing the processes seen in the ITC exper-
iments and implicated by the obtained Ca2CaM/SPC
crystal structure. We carried out rapid mixing experi-
ments with both apo and Ca2-saturated dansyl-CaM
binding to SPC micelles (Fig. 7). The reaction of
Ca2CaM with SPC at the applied concentrations was
too fast to be measured; the entire signal change was
lost in the dead time of the stopped-flow apparatus (2
ms). Therefore, we could analyze the final fluorescence
levels but not the kinetics of the fluorescence change.
In the case of apoCaM, however, we could obtain
transients on binding to 50 M SPC (Fig. 7A). Similarly
to the changes previously observed in equilibrium
measurements (13), we obtained a large fluorescence
increase on binding. The intensity increase partitioned
into three kinetically distinguishable phases. The first,
fast phase can only be inferred from the shift in the
initial observed fluorescence compared to the reaction
with buffer as the time course is lost in the dead time.
This fast, initial fluorescence increase has the largest
amplitude of all phases and most likely represents the
collision complex of a dansyl-CaM molecule with a
micelle. The second phase displayed concentration
dependence only above 1 M CaM concentration (Fig.
7B). Below 1 M CaM, an apparently first-order process
having a rate constant of 77  4 s1 is observed. The
concentration-dependent part of the curve can be
fitted with a linear function with a second-order rate
constant of 79  10 M1s1. The third kinetic
phase appears also above 1 M CaM concentration
and has a rate constant of 12  4 s1.
The concentration dependence of the total fluo-
rescence change (Fig. 7C, inset) could be fitted with
a quadratic function yielding an apparent Kd 
0.05  0.03 M. The apparent concentration of the
interacting species from the quadratic fit is 0.36 M.
Given that the SPC monomer concentration was 50
M, the interacting micelle should consist of 140
monomers, a number close to the one estimated
from the ITC experiments (Table 2). Considering
the monophasic nature of the saturation curve and
that the obtained Kd and monomers/micelle ratio
values are close to the ones observed in the first ITC
Figure 6. Monitoring micelle integrity with ANS fluorescence.
200 M SPC was titrated with Ca2CaM (E) or apoCaM ()
similarly to ITC measurements, only monitoring the fluores-
cence of ANS instead of released heat. Disruption of micelles
occurs in the same range of molar ratios as the second phase
of ITC measurements.
Figure 7. Kinetic analysis of the CaM–SPC interaction. A) Time courses of 50 M
SPC binding to 0, 0.2, 0.4, 0.5, 1, 2, 3, or 4 M apoCaM, as reported by dansyl-CaM
fluorescence in a stopped-flow experiment. Smooth lines through the data
represent the best exponential fits (double exponentials to the 0.4–0.8 M, and
triple exponentials to the 1–4 M CaM data). Note the logarithmic time scale and
y axis break applied for better viewing. B) Concentration dependence of the
observed rate constants of the two slower phases extracted from time courses
shown (A). The first kinetic phase was lost in the dead time of the stopped-flow
apparatus. C) Concentration dependence of the total signal amplitudes observed
in time courses recorded on mixing 50 M SPC with various concentrations of apo
() or Ca2 (E) CaM. A quadratic fit to the saturating apo CaM curve yielded a
Kd of 0.05 0.03 M and an apparent concentration of 0.36 M for SPC, implying
140 monomers/micelle. The Ca2CaM curve was fitted with a double quadratic
equation and yielded Kd,1  0.02  0.07 M and an apparent SPC concentration of 0.44 M (114 monomers/micelle),
Kd,2  0.43  0.80 M and an apparent SPC concentration of 18 M (3 monomers/interacting species). D) Fluorescence
change data from C is calculated in molar ratios to show a graph comparable to the ITC results.
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binding phase, we presume that the dansyl fluores-
cence predominantly reports on this first process,
and only a small-amplitude fraction reports on the
second one. Therefore, the equilibrium constant of
the two processes cannot be resolved, and the appar-
ent Kd lies in between the relevant ones of the ITC
measurement (Table 2). On the other hand, plotting
the signal change in function of the molar ratios as
done when displaying ITC data (Fig. 7D, inset), it is
apparent that the stoichiometry dependence of the
second phase and the appearance of the third phase
coincide with the appearance of the second ITC
process at molar ratio  0.02. This may indicate that
we can observe the binding of additional CaMs to the
CaM-micelle complex (concentration-dependent sec-
ond phase) and a subsequent conformational change
coupled to it (third kinetic phase). These events are
much slower than the formation of the initial com-
plex likely involving only one CaM binding to a
micelle.
The concentration and stoichiometry dependence of
the total fluorescence change on Ca2CaM binding to
SPC can be seen in Fig. 7C, D, respectively. The smooth
line through the data in Fig. 7C represents the best
double quadratic fit yielding Kd,1  0.02 0.07 M and
Kd,2  0.43  0.80 M. The large fitting errors restrain
us to resolve only the order of magnitude of the two
Kds, not their precise values. Nevertheless, two distinct
processes can clearly be observed with a significant
difference between the two dissociation constants. The
apparent SPC concentrations from the quadratic fits
(0.44 and 18 M) imply that the interacting entities
consist of 114 and 3 monomers in the first and
second process, respectively. Relative Kds and the
monomer numbers of the CaM-interacting partners are
close to the ones calculated from the ITC experiments,
suggesting that we observed the same events in both
experimental setups. Comparing Fig. 7D with Fig. 4, it is
even more striking that the same processes are ob-
served using two utterly different techniques. Further-
more, the 3 SPC/Ca2CaM ratio determined in solu-
tion is very close to the stoichiometry of the complex
resolved in our crystal (4 SPC/Ca2CaM) and inferred
from the ITC experiments (7 SPC/Ca2CaM). This
implies that our observations in the crystal and in the
solution phase apply to the same phenomenon and
consistently describe a uniform system.
SPC disrupts the interaction between CaM and
CaM-binding proteins of cerebral microsomes
To assess the possible functional consequences of the
binding mechanism described here in detail, we ex-
plored the effect of SPC on CaM bound to its targets on
a cerebral microsomal fraction mimicking the intracel-
lular environment. We used dansyl-CaM to monitor the
state of CaM in the preparation, because the fluores-
cence of dansyl-CaM increases when bound to target
proteins compared to the free or SPC-bound form (29,
37). Figure 8 reveals that in the presence of micro-
somes, dansyl-CaM exhibits increased fluorescence,
while the addition of SPC suppresses intensity to the
level of dansyl-CaM bound to SPC alone. These results
indicate that the addition of SPC to cerebral micro-
somes displaces CaM from its targets. The displacement
is selective to SPC as other structurally related lysophos-
pholipids, such as LPC or LPA, did not show the effect
(Fig. 8A). The dose response for SPC yielded an IC50 of
94.4  2.2 M (Fig. 8B). This value is 5-fold higher
than we would expect from peptide binding assays (29)
and also higher than one would estimate cellular SPC
levels to be. However, we should take into account the
significant amount of endogenous CaM (and other
possible SPC-binding proteins) in such cellular frac-
tions, and that all CaM, endogenous and dansyl-la-
beled, should equally be displaced from its targets in
order to get a complete signal from the dansyl fluoro-
phore. We should also keep in mind that CaM regula-
tion by SPC is most probably a highly localized one, and
Figure 8. Disruption of complexes between CaM and its
targets on cerebral microsomes by SPC. A) Spectra of 0.2 M
Ca2-saturated dansyl-CaM alone (dotted trace), with 100 M
SPC (broken trace), with 0.5 mg/ml microsomal protein
(solid trace), with 0.5 mg/ml microsomal protein and 100
M SPC (E), with 0.5 mg/ml microsomal protein and 100
M LPC (‚) and with 0.5 mg/ml microsomal protein and
100 M LPA (ƒ). Spectra are representatives of three sepa-
rate measurements. B) Concentration dependence of the
complex dissociating ability of SPC. Ca2-saturated dansyl-
CaM and microsomal protein concentrations were 0.2 M
and 0.5 mg/ml, respectively. Fitting a sigmoidal dose-re-
sponse function yielded an IC50 value of 94.4  2.2 M. Data
points depict means  se (n3).
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therefore, it does not require the inhibition of a large
amount of CaM-target interactions globally, as in our
experimental setup.
DISCUSSION
Previously, we have shown that the putative lipid second
messenger SPC is capable of selectively inhibiting CaM
in vitro (13). This finding is of particular importance, as
it proposes an intracellular target site for SPC and also
suggests an utterly novel type of in vivo regulation for
the well-known Ca2 sensor protein CaM. The so far
characterized CaM inhibitors are all synthetic (6–8) or
occur only in specific species (9, 10), while SPC is
presumably present in most eukaryotic cells as an
intermediate of sphingolipid metabolism (11, 12).
Moreover, we have demonstrated that SPC can bind
to CaM efficiently only if it is clustered, which form is
manifested in micelles in vitro, raising several intrigu-
ing questions about lipid-protein interactions. It is
for the above reasons that we examined the CaM–
SPC interaction using several independent biochem-
ical and biophysical methods that allow evaluation of
distinct features of the binding process. On the basis
of our results, we propose a complex and consistent
model of CaM binding to SPC both in the presence
and absence of Ca2.
As Ca2CaM is the functionally more important and
better-characterized species, we present a detailed
model on the Ca2CaM–SPC interaction (Fig. 9). Both
ITC and stopped-flow measurements revealed a strong
binding of Ca2CaM to SPC (Kd of 60 nM and 20 nM,
respectively) with a stoichiometry, suggesting that the
protein binds to micelles (values of 100–200 and 114
SPC/Ca2CaM, respectively). DLS measurements veri-
fied this concept as the size of this species was deter-
mined to be significantly larger than SPC micelles or
CaM alone. The driving force of this interaction is
probably an electrostatic attraction between the posi-
tively charged choline groups of SPC and the negatively
charged residues of CaM. This notion is aided by the
fact that SPC micelles are supposedly perceived as
positively charged spheres with their hydrophobic car-
bon chains buried inside, and also that this phase was
shown to be entirely enthalpically driven in ITC exper-
iments.
ITC and stopped-flow measurements also demon-
strated that a second process takes place during bind-
ing of Ca2CaM to SPC micelles, which occurs when
micelles become limiting. This second process results
in a complex with an estimated stoichiometry of 3–7
SPC monomers/protein. As our crystal structure of the
Ca2CaM/SPC complex revealed that Ca2CaM can
adopt a collapsed conformation wrapped around a few
SPC molecules (4 in our structure), we hypothesized
that the species resulting from the second process is
identical to the one that we see in the crystal structure.
This concept was supported by DLS experiments since
the size of this species was significantly smaller than
micelles or the protein alone. Furthermore, fluores-
cence measurements with ANS clearly demonstrated
that micelles are disrupted during the second process.
This species strikingly resembles the collapsed con-
formation of CaM, which the protein adopts on
binding to target peptides or synthetic inhibitors
Figure 9. Stoichiometry-dependent binding model for the Ca2CaM–SPC interaction. The SPC micelle is represented as a
sphere with a radius of 30 Å. Molecular surfaces are colored according to surface charge distribution (red, negative; blue,
positive). First process (steps 1 and 2): Ca2CaM molecules bind to the positively charged micelle. Electrostatic interaction with
the acidic CaM regions is important in this phase. Second process (step 3): Saturation of the micelle surface with protein
molecules will eventually result in the disintegration of the micelle and Ca2CaM adopting a collapsed conformation
(transparent view) embracing several SPC monomers (gray). In this phase, hydrophobic interactions play an important
role in complex formation. The exact mechanism by which the protein disintegrates the micelle is unknown, as depicted by the
dashed arrow. Crystal structures of Ca2CaM (PDB structure 1UP5) and Ca2CaM/SPC (PDB structure 3IF7) were used for modeling
the complexes. Note that while the Ca2CaM–SPC micelle complex is only a model, the structure of the resulting Ca2CaM/SPC
complex has been determined by X-ray crystallography. The figure was prepared using PyMol (DeLano Scientific).
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(Fig. 3). Intriguingly, the peptide binding site of
CaM is now occupied by several lipid molecules.
Since the exact positions of the SPC headgroups were
ambiguous to some extent in the crystal structure,
hydrophobic interactions between the aliphatic
chain of the lipid and the hydrophobic residues of
the protein are more likely to contribute to the
stabilization of this complex.
We envision that the surface of SPC micelles are
coated by CaM, until there is not enough free space for
the negatively charged protein to bind to the positive
surface provided by the choline headgroups of SPC
without sterically hindering each other (Fig. 9). As
micelles are dynamic structures, we propose that they
fluctuate during the competition of CaM molecules for
their positive surface, which leads to the appearance of
the collapsed protein conformation engulfing several
lipid monomers. CaM molecules embracing several
SPC monomers continuously leave the micelle-protein
complex, thus gradually resulting in disintegration of
the micelle. It is important to emphasize that this
scenario only pictures one possible way the two species
(CaM bound to micelles and the collapsed conforma-
tion) might arise, other possibilities also exist. What we
have demonstrated unambiguously is the stoichiome-
try-dependent appearance of the two species, both of
which are inhibitory. The lipid shields the target pep-
tide binding sites in both CaM conformations, resulting
in an inhibitory effect in enzyme activity (13) and
peptide-binding assays (29).
The binding of apoCaM resembles that of Ca2CaM,
as it can be described by similar two processes, but with
a difference in the complex arising in the second
phase. The apoCaM-SPC complex can be characterized
by a stoichiometry of 40 SPC monomers/protein and
is larger than the one appearing in the presence of
Ca2. Presumably, this phenomenon can be explained
by the fact that apoCaM is unable to adopt a collapsed
conformation with a hydrophobic binding channel
surrounded by acidic residues as Ca2CaM can. The
fact that apoCaM can bind to SPC makes SPC unique
among CaM inhibitors since the classical CaM inhibi-
tors are unable to bind to apoCaM (8, 32). This special
behavior might be explained by the fact that the
binding of the protein to the micelle is almost entirely
driven by electrostatic forces, as the hydrophobic
chains of the lipid are buried within the micelle.
Hence, the open hydrophobic patches of the protein
are not required in the initial stage of binding. In
contrast, traditional aromatic inhibitors bind as mono-
mers, offering mostly the possibility of hydrophobic
interactions with CaM. The unique property of SPC—
that it binds to both apo and Ca2CaM—raises the
possibility of an entirely new regulation of proteins that
constitutively bind CaM (38).
We have demonstrated that SPC is capable of displac-
ing CaM from its targets on cerebral microsomes,
indicating that the interaction that we have structurally
extensively characterized might have important impli-
cations in cellular signaling. A membrane surface en-
riched in SPC might serve as an in vivo equivalent for
the SPC surface presented by micelles in vitro. It is
important to note that the precise affinity and stoichi-
ometry values determined here characterize the pro-
tein-micelle system and should not be directly applied
to cellular conditions. What our model reveals about
the in vivo lipid-protein interaction is the following:
1) CaM interacts with SPC clusters at high (nanomolar)
affinity; 2) once the SPC-CaM complex forms, it can
adopt different conformations depending on several
factors, most likely on the curvature and size of the lipid
cluster and the local abundance of CaM. The fact that
the interaction can manifest itself in both mixed lipid
(13, 29) and protein (measurements on cerebral mi-
crosomes) environments points to the plausibility of
the same phenomenon to occur under cellular condi-
tions.
In summary, we present a structural model for the
binding of CaM to the lipid mediator SPC. At low
protein-to-lipid ratios, CaM binds to intact micelles,
whereas at high protein-to-lipid ratios micelles are
disintegrated by the protein, eventuating in a com-
pact globular conformation of Ca2CaM, also visual-
ized in our crystal structure. Both the micelle-bound
and the collapsed conformation are inhibitory, as the
lipid shields the binding sites for target peptides,
potentially having important consequences in cell
signaling. Moreover, this unique 2-step binding
model describes a novel and peculiar biochemical
mechanism, which reveals how versatile a lipid-
protein interaction can be.
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